|
CA3049274A1
|
|
Vegfr-2 antibodies
|
|
EP3565898A1
|
|
Vegfr-2 car immune cells to treat cancers
|
|
WO2018126315A1
|
|
Anti-vegfr-2 urease conjugates
|
|
CA3045327A1
|
|
Restoring function of tumour acidified t cells
|
|
KR20190057275A
|
|
CAR Immune Cells for Cancer Embryonic Antigen Associated Cell Adhesion Molecules 6 to Treat Cancer
|
|
AU2016210551A1
|
|
Antibody-urease conjugates for therapeutic purposes
|
|
WO2015023601A1
|
|
Biphasic lipid-vesicle compositions and methods for treating cervical dysplasia by intravaginal delivery
|
|
AU2014252666A1
|
|
Use of antibody-urease conjugates for diagnostic and therapeutic purposes
|
|
US2015044274A1
|
|
Biphasic lipid-vesicle compositions and methods for treating cervical dysplasia by intravaginal delivery
|
|
KR20090130081A
|
|
Biphasic lipid-vesicle composition and method for treating cervical dysplasia by intravaginal delivery
|
|
CA2493282A1
|
|
Method and composition for inhibiting cancer cell growth using urease and weakly basic anti-cancer compounds
|
|
US2005196391A1
|
|
Method and composition for inhibiting cancer cell growth
|
|
BR0312664A
|
|
Pharmaceutical composition and use of the enzyme urease for the manufacture of a medicament for treating cancer cells in an individual
|
|
CA2483150A1
|
|
Protein interaction system for multisubunit complexes
|
|
CA2458227A1
|
|
Method and device for integrated protein expression, purification and detection
|
|
CA2420743A1
|
|
Biosensor assay device and method
|
|
WO0052456A1
|
|
Biosensor device and method
|
|
WO0052457A1
|
|
Card-based biosensor device
|
|
AU3134199A
|
|
Antimicrobial betaGalNAc(1-4)betaGal derivatives and methods of use
|
